课题基金 / 基金详情

WHAT IS THE EVIDENCE BEHIND THE RECOMMENDATION OF WITHHOLDING CERTAIN MEDICATION BEFORE CONTRAST PROCEDURES? A SYSTEMATIC REVIEW OF THE EVIDENCE.

WHAT IS THE EVIDENCE BEHIND THE RECOMMENDATION OF WITHHOLDING CERTAIN MEDICATION BEFORE CONTRAST PROCEDURES? A SYSTEMATIC REVIEW OF THE EVIDENCE.
建议在对比程序之前停止服用某些药物的证据是什么?
批准号:
346047
负责人:
Hiremath Swapnil
金额:
$7.21万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-01-01 至 2017-01-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
<html> <body> <p>The guidelines on the prevention of contrast induced&nbsp;acute kidney injury(CI-AKI)&nbsp;recommend holding certain medications such as angiotensin converting enzyme inhibitors (ACE-i), angiotensin receptor blockers (ARB), non steroida
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金